BPH Treatment Decisions for Men Under 60 — What Changes

Men under 60 with BPH face a treatment calculus that differs materially from the typical 65+ patient. Two factors dominate: (1) longer remaining life expectancy means higher cumulative retreatment probability, and (2) sexual function — both erectile and ejaculatory — carries greater weight in quality-of-life priorities.

The retreatment math for younger patients

A 55-year-old choosing between a procedure with 5% vs. 13% five-year retreatment faces a 25-year gap between procedure and typical life expectancy. At 5% per five years (compounding), the cumulative retreatment probability over 25 years is approximately 23%. At 13%, it approaches 50%. These are rough projections — but the directional difference is material.

Sexual function: the under-discussed priority

Multiple patient surveys confirm that men under 60 rank ejaculation preservation above durability when choosing BPH treatment. The standard urology consultation often prioritizes durability — reflecting the physician's clinical framework rather than the patient's values. A shared decision-making approach should explicitly surface these preference weights.

MIST-first as a deliberate strategy

For younger patients, a MIST-first approach — choosing a low-morbidity, ejaculation-preserving procedure now while keeping TURP or laser as a future option — is increasingly recognized as a rational treatment pathway. The key is choosing a MIST procedure with the lowest retreatment rate and highest preservation profile available.